Synagis and Venoocclusive liver disease - a phase IV clinical study of FDA data


No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

On Sep, 25, 2023

No or too few reports are found.

What is Synagis?

Synagis has active ingredients of palivizumab. Currently, eHealthMe is studying from 18,180 Synagis users.

What is Venoocclusive Liver Disease?

Venoocclusive liver disease (small veins in the liver are obstructed) is found to be associated with 612 drugs and 365 conditions by eHealthMe. Currently, we are studying 5,519 people who have Venoocclusive liver disease.

Do you take Synagis and have Venoocclusive liver disease?

Check whether Venoocclusive liver disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Venoocclusive liver disease and when was it recovered:

Expand to all the drugs that have ingredients of palivizumab:

Alternative drugs to, pros and cons of Synagis:

Browse all side effects of Synagis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Venoocclusive liver disease treatments and more:

All the drugs that are associated with Venoocclusive liver disease:

All the conditions that are associated with Venoocclusive liver disease:

How the study uses the data?

The study uses data from the FDA. It is based on palivizumab (the active ingredients of Synagis) and Synagis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: